InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,173.49
(
-0.27%
)
US TECH 100
17,508.00
(
-0.60%
)
Dow Jones
38,874.94
(
-0.02%
)
Brent Oil
82.17
(
-0.84%
)
Bitcoin
61,891.39
(
-0.71%
)
Post# of 689615
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

longfellow95

Send PM Follow Ignore
Followers 46
Posts 5645
Boards Moderated 0
Alias Born 04/05/2015

longfellow95

Re: None

Sunday, 03/17/2019 6:55:24 PM

Sunday, March 17, 2019 6:55:24 PM

Post# of 689615
"Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors."

613 deaths in clinical trials.
This is likely to be a gross under-report and not include HPD.
Deaths in regular clinical practice will be many times this figure.

https://www.researchgate.net/profile/Joe_Salem/publication/327739151_Fatal_Toxic_Effects_Associated_With_Immune_Checkpoint_Inhibitors_A_Systematic_Review_and_Meta-analysis/links/5ba4af14a6fdccd3cb67ca0e/Fatal-Toxic-Effects-Associated-With-Immune-Checkpoint-Inhibitors-A-Systematic-Review-and-Meta-analysis.pdf?origin=publication_detail
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News
InvestorsHub NewsWire

FEATURED Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • May 8, 2024 9:05 AM

Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM

Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM

Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM

Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • BLOZF • May 7, 2024 8:51 AM

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

Start posting your company's news
Only $200 per official company press release!